Open help menu
In Person
The Miami Symposium 2025: Interdisciplinary Solutions to Mental Health Challenges: From Precision Medicine to Transcranial Magnetic Stimulation

Latest Advancements of TMS in Research

Andrew Leuchter, MD
Shan Siddiqi, MD
|

Information

Date & Time

Description

Advances in the Use of TMS for Difficult to Reach Neuropsychiatric Illnesses
Presented by Dr. Andrew Leuchter
This course examines the latest advances in Transcranial Magnetic Stimulation (TMS) for treating difficult-to-treat neuropsychiatric conditions, including major depression, obsessive-compulsive disorder, and substance use disorders. Participants will explore emerging protocols, evidence-based applications, and clinical strategies to optimize patient outcomes. Emphasis is placed on understanding neurocircuitry targets, integrating TMS into comprehensive treatment plans, and translating research into practical, real-world clinical care.

Circuit-targeted Neuromodulation Across Symptoms and Disorders
Presented by Dr. Shan Siddiqi
This course explores circuit-targeted neuromodulation as a precision approach for treating neuropsychiatric symptoms across diverse disorders. Participants will learn how interventions like TMS and other neuromodulatory techniques can modulate specific brain circuits to improve clinical outcomes. Emphasis is placed on understanding neurocircuitry, identifying symptom-specific targets, and integrating evidence-based neuromodulation strategies into personalized treatment plans.

Educational Goal

This presentation highlights how advanced TMS protocols can effectively target neurocircuitry involved in treatment-resistant neuropsychiatric disorders. Attendees will gain insights into evidence-based strategies, emerging applications, and practical approaches for integrating TMS into comprehensive patient care. This presentation emphasizes how targeting specific neural circuits with neuromodulation can address symptoms across multiple neuropsychiatric disorders. Attendees will gain practical insights into selecting appropriate targets, optimizing intervention strategies, and applying circuit-based approaches to enhance patient outcomes.

Learning Objectives

Participants will be able to:

  • Describe at least one emerging application of TMS.

  • Identify two evidence-based strategies to integrate TMS into comprehensive treatment plans.

  • Explain neurocircuitry targets.

  • Apply circuit-based approaches to enhance patient outcomes.

  • Define and describe neurocircuitry.

  • Explain how TMS and other neuromodulatory techniques modulate specific brain circuits to improve clinical outcomes.

  • Evaluate how to select appropriate circuit targets.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Andrew Leuchter, MD
Andrew F. Leuchter, MD, is a Distinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior, Executive Vice Chair of the Department of Psychiatry and Biobehavioral Sciences, and Associate Director of the Semel Institute. He also is Director of the Neuromodulation Division at the Semel Institute. Dr. Leuchter is a graduate of Stanford University and the Baylor College of Medicine who joined the UCLA faculty in 1986. An expert on the treatment of mood disorders, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of the largest academic TMS program in the country, which performs more than 6,000 treatments each year for patients with depression, pain, and other neuropsychiatric illness. Dr. Leuchter has authored over 200 scientific articles on topics including neuromodulation for the treatment of depression, EEG biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He teaches internationally on TMS and other neuromodulation methods, and received the 2019 Outstanding Research Mentor Award from the Semel Institute.
Shan Siddiqi, MD
Shan Siddiqi is an assistant professor of psychiatry at Harvard Medical School, a neuropsychiatrist at Brigham & Women’s Hospital, and director of psychiatric neuromodulation research for the Center for Brain Circuit Therapeutics. His research is focused on causal mapping of human brain function and dysfunction. Using techniques such as functional connectivity MRI, his lab maps brain circuits to link brain lesions and brain stimulation sites that can modify different psychiatric symptoms. These circuits can then be targeted with treatments such as transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS) to alleviate symptoms in psychiatric disorders. His work has been recognized with multiple awards from the Brain & Behavior Research Foundation, the American Neuropsychiatric Association, the American College of Neuropsychopharmacology, Harvard Medical School, and many others.